ICAR PEDIATRIC SUSP OTC
Generic Name and Formulations:
Iron (as carbonyl) 15mg/1.25mL; grape flavor; sugar- and alcohol-free.
Indications for ICAR PEDIATRIC SUSP:
Iron deficiency and iron deficiency anemia.
1 tab once daily.
Use Ped Susp. 15mg (of iron) once daily.
Folic acid may mask pernicious anemia. Monitor hemoglobin, hematocrit, reticulocyte count periodically. Elderly.
Inhibits tetracycline absorption. Aluminum- or magnesium-containing antacids inhibit iron absorption.
Nausea, abdominal discomfort and pain, constipation, diarrhea, masks occult bleeding, black stools.
Ped Susp—4oz (w. dosing syringe)
Clinical Pain Advisor Articles
- Chronic Neuropathic Pain Updated Classification by IASP for ICD-11
- Buprenorphine-Naloxone Found to Be More Cost-Effective Than Extended-Release Naltrexone
- Ultrasound-Guided C2 Coblation May Be Effective for Cervicogenic Headache
- Meta-Analysis of Opioid Treatment for Chronic Noncancer Pain
- Opioids Found to Increase Risk for Community-Acquired Pneumonia, Particularly in HIV
- Reviewing the Use of Buprenorphine in Perioperative Pain Management
- Early Physical Therapy for Musculoskeletal Pain May Reduce Opioid Use
- External Trigeminal Nerve Stimulation May Alleviate Migraine Pain
- IASP Updates Diagnosis Criteria for Chronic Primary Pain for ICD-11
- Galcanezumab Provides Persistent Preventive Effects in Episodic, Chronic Migraine
- Comparable Analgesia With Low-Dose IV Ketamine, Morphine for Acute Pain
- Benzodiazepines, if Prescribed, May Not Affect Methadone Treatment Retention
- When Opioid Prescribing Guidelines Become Rules
- IV Fluid Confers No Significant Treatment Effect on Migraine Pain
- American Headache Society Releases Position Statement on Novel Preventive and Acute Migraine Treatments